Literature DB >> 33660297

Susceptibility and resistance in leprosy: Studies in the mouse model.

Linda B Adams1.   

Abstract

Leprosy is a chronic granulomatous infectious disease caused by the pathogen, Mycobacterium leprae, and the more recently discovered, M. lepromatosis. Described in 1873, M. leprae was among the first microorganisms to be proposed as a cause of a human infectious disease. As an obligate intracellular bacterium, it has still not thus far been reproducibly cultivated in axenic medium or cell cultures. Shepard's mouse footpad assay, therefore, was truly a breakthrough in leprosy research. The generation of immunosuppressed and genetically engineered mice, along with advances in molecular and cellular techniques, has since offered more tools for the study of the M. leprae-induced granuloma. While far from perfect, these new mouse models have provided insights into the immunoregulatory mechanisms responsible for the spectrum of this complex disease. Published 2021. This article is a U.S. Government work and is in the public domain in the USA. Immunological Reviews published by John Wiley & Sons Ltd.

Entities:  

Keywords:  zzm321990M. lepraezzm321990; zzm321990M. lepromatosiszzm321990; NOS2; clofazimine; interferon-gamma; interleukin-17

Year:  2021        PMID: 33660297     DOI: 10.1111/imr.12960

Source DB:  PubMed          Journal:  Immunol Rev        ISSN: 0105-2896            Impact factor:   12.988


  2 in total

1.  A Sensitive and Quantitative Assay to Enumerate and Measure Mycobacterium leprae Viability in Clinical and Experimental Specimens.

Authors:  Jaymes H Collins; Shannon M Lenz; Nashone A Ray; Marivic F Balagon; Deanna A Hagge; Ramanuj Lahiri; Linda B Adams
Journal:  Curr Protoc       Date:  2022-02

2.  Pyrethroid Resistance Situation across Different Eco-Epidemiological Settings in Cameroon.

Authors:  Nelly Armanda Kala-Chouakeu; Paulette Ndjeunia-Mbiakop; Idriss Nasser Ngangue-Siewe; Konstantinos Mavridis; Vasileia Balabanidou; Roland Bamou; Mabu Maxim Bindamu; Abdou Talipouo; Landre Djamouko-Djonkam; Jean Arthur Mbida-Mbida; Jeanette Tombi; John Vontas; Timoléon Tchuinkam; Christophe Antonio-Nkondjio
Journal:  Molecules       Date:  2022-09-26       Impact factor: 4.927

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.